Background Vancomycin-resistant enterococci are a leading cause of hospital-acquired urinary tract infection and a growing concern for the clinician. The aim of this study was to evaluate the ...

B. 264, 1629–1638 (1997). Bonten, M.J. et al. Epidemiology of colonisation of patients and environment with vancomycin–resistant enterococci. Lancet 348, 1615–1619 (1996). Austin ...

The purpose of this Guidance Document for Disinfectants and Sterilization Methods is to assist lab personnel in their decisions involving the judicious selection and proper use of specific ...

inhibiting peptidyl transfer Quinupristin binds also to the 50S ribosomal subunit and prevents elongation of the polypeptide Gram-positive cocci and vancomycin-resistant Enterococcus faecium ...

Vancomycin-Resistant Enterococcus and Penicillin-Resistant Streptococcus pneumoniae. The company was founded by David P. Luci, Robert G. Shawah and Robert J. DeLuccia in July 2017 and is ...

Full vancomycin resistance reported (2002) In 2002, specialists reported the first full vancomycin-resistant strain of Staph aureus. By definition, such strains require a dose of vancomycin ...

Good infection prevention in hospitals helps stop its spread. Vancomycin-intermediate (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) are forms of the bug that have become resistant to ...

thereby limiting overgrowth of pathogenic organisms such as VRE (vancomycin resistant Enterococci) and reducing the incidence and severity of acute graft-versus-host-disease (aGVHD) in allogeneic ...

Theriva™ Biologics (NYSE American: TOVX), (“Theriva” or the “Company”) a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet ...

Primary endpoint met with high rates of clinical cure at day 12 . Very low rates of recurrence observed with CRS3123. CRS3123 was generally safe and well tolerated. NIAID exercise ...

My work is focused on the study of the bacterial cell wall using essentially two Gram-positive pathogens (Staphylococcus aureus, Enterococcus faecalis) as models. I am interested in three major areas ...